| Year |
Citation |
Score |
| 2024 |
Wang R, Hu P, Wang F, Lyu J, Ou Y, Edderkaoui M, Zhang Y, Lewis MS, Pandol SJ, Zhau HE, Chung LWK. Spontaneous Fusion with Transformed Mesenchymal Stromal Cells Results in Complete Heterogeneity in Prostate Cancer Cells. Cancers. 16. PMID 38473313 DOI: 10.3390/cancers16050951 |
0.422 |
|
| 2022 |
Lo UG, Chen YA, Cen J, Deng S, Luo J, Zhau H, Ho L, Lai CH, Mu P, Chung LWK, Hsieh JT. The driver role of JAK-STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy- and castration-resistant prostate cancer. Clinical and Translational Medicine. 12: e978. PMID 35908276 DOI: 10.1002/ctm2.978 |
0.518 |
|
| 2022 |
Lee CF, Chen YA, Hernandez E, Pong RC, Ma S, Hofstad M, Kapur P, Zhau H, Chung LW, Lai CH, Lin H, Lee MS, Raj GV, Hsieh JT. The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): A new targeted therapy of NEPC. Clinical and Translational Medicine. 12: e695. PMID 35184376 DOI: 10.1002/ctm2.695 |
0.583 |
|
| 2021 |
Smith B, Kim S, Tighiouart M, Posadas E, Chung L, Figlin R, Bhowmick N, Gong J. Plasma Glutamine as a Prognostic Biomarker in Localized Prostate Cancer: Comparison of Conventional Variables in Risk Stratification. Oncology (Williston Park, N.Y.). 35: 528-535. PMID 34524771 DOI: 10.46883/ONC.2021.3509.0528 |
0.465 |
|
| 2021 |
Cao Z, Shi X, Tian F, Fang Y, Wu JB, Mrdenovic S, Nian X, Ji J, Xu H, Kong C, Xu Y, Chen X, Huang Y, Wei X, Yu Y, ... ... Chung LWK, et al. KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer. Cell Death & Disease. 12: 2. PMID 33414463 DOI: 10.1038/s41419-020-03354-4 |
0.608 |
|
| 2020 |
Adashek JJ, Reed JP, Tandon A, Freedland SJ, Posadas E, Bhowmick N, Chung LW, Freeman M, Figlin RA, Gong J. Combination Androgen Receptor Inhibition and Docetaxel in Metastatic Castration-sensitive Prostate Cancer: The Next Step in First-line Treatment? Clinical Genitourinary Cancer. PMID 32631766 DOI: 10.1016/J.Clgc.2020.05.003 |
0.479 |
|
| 2020 |
Yin L, Hu P, Shi X, Qian W, Zhau HE, Pandol SJ, Lewis MS, Chung LWK, Wang R. Cancer cell's neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction. Scientific Reports. 10: 1216. PMID 31988304 DOI: 10.1038/s41598-020-58118-z |
0.515 |
|
| 2019 |
Wang R, Lewis MS, Lyu J, Zhau HE, Pandol SJ, Chung LWK. Cancer-stromal cell fusion as revealed by fluorescence protein tracking. The Prostate. PMID 31846114 DOI: 10.1002/pros.23941 |
0.344 |
|
| 2019 |
Zhang D, He D, Xue Y, Wang R, Wu K, Xie H, Zeng J, Wang X, Zhau HE, Chung LWK, Chang LS, Li L. Editor's Note: PrLZ Protects Prostate Cancer Cells from Apoptosis Induced by Androgen Deprivation via the Activation of Stat3/Bcl-2 Pathway. Cancer Research. 79: 6054. PMID 31791961 DOI: 10.1158/0008-5472.CAN-19-3162 |
0.563 |
|
| 2019 |
Hsieh CL, Huang HS, Chen KC, Saka T, Chiang CY, Chung LWK, Sung SY. A novel salicylanilide derivative induces autophagy cell death in castration-resistant prostate cancer via ER stress-activated PERK signaling pathway. Molecular Cancer Therapeutics. PMID 31530650 DOI: 10.1158/1535-7163.MCT-19-0387 |
0.495 |
|
| 2019 |
Jan YJ, Yoon J, Chen JF, Teng PC, Yao N, Cheng S, Lozano A, Chu GCY, Chung H, Lu YT, Chen PJ, Wang JJ, Lee YT, Kim M, Zhu Y, ... ... Chung LWK, et al. A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer. Theranostics. 9: 2812-2826. PMID 31244925 DOI: 10.7150/thno.34485 |
0.337 |
|
| 2019 |
Wang R, Chu GC, Wang X, Wu JB, Hu P, Multani AS, Pathak S, Zhau HE, Chung LWK. Establishment and characterization of a prostate cancer cell line from a prostatectomy specimen for the study of cellular interaction. International Journal of Cancer. PMID 31020641 DOI: 10.1002/ijc.32370 |
0.574 |
|
| 2019 |
Chu GC, Chung LWK, Gururajan M, Hsieh CL, Josson S, Nandana S, Sung SY, Wang R, Wu JB, Zhau HE. Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics. Asian Journal of Urology. 6: 65-81. PMID 30775250 DOI: 10.1016/J.Ajur.2018.11.003 |
0.369 |
|
| 2019 |
Hsiao WC, Sung SY, Chung LWK, Hsieh CL. Osteonectin Promoter-Mediated Suicide Gene Therapy of Prostate Cancer. Methods in Molecular Biology (Clifton, N.J.). 1895: 27-42. PMID 30539527 DOI: 10.1007/978-1-4939-8922-5_3 |
0.445 |
|
| 2019 |
Tripathi M, Nandana S, Huang J, Kato M, Mishra R, Chung L, Xin L, Bhowmick N. Abstract 5164: Signaling crosstalk within prostate tumor microenvironment mediates castrate resistant disease progression Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-5164 |
0.528 |
|
| 2019 |
Nandana S, Gururajan M, Tripathi M, Chu C, Zhau H, Shiao S, Chung L. Abstract 4523: A novel syngeneic mouse model of prostate cancer bone metastasis: Mechanisms of chemotaxis and bone colonization Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-4523 |
0.536 |
|
| 2019 |
Xiong M, Wang F, Zhau HE, Huang X, Chung L, Zhang J, Lu Y. Abstract 3295: GPRASP1:A novel potential biomarker for neuroendocrine carcinoma Cancer Research. 79: 3295-3295. DOI: 10.1158/1538-7445.Am2019-3295 |
0.465 |
|
| 2018 |
Rotinen M, You S, Yang J, Coetzee SG, Reis-Sobreiro M, Huang WC, Huang F, Pan X, Yáñez A, Hazelett DJ, Chu CY, Steadman K, Morrissey CM, Nelson PS, Corey E, ... Chung LWK, et al. ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis. Nature Medicine. PMID 30478421 DOI: 10.1038/s41591-018-0241-1 |
0.626 |
|
| 2018 |
Reis-Sobreiro M, Chen JF, Novitskaya T, You S, Morley S, Steadman K, Kaur Gill N, Eskaros A, Rotinen M, Chu CY, Chung LWK, Tanaka H, Yang W, Knudsen BS, Tseng HR, et al. Emerin deregulation links nuclear shape instability to metastatic potential. Cancer Research. PMID 30154147 DOI: 10.1158/0008-5472.Can-18-0608 |
0.561 |
|
| 2018 |
Lin TP, Li J, Li Q, Li X, Liu C, Zeng N, Huang JM, Chu CY, Lin CH, Zhau HE, Chung LWK, Wu BJ, Shih JC. R1 Regulates Prostate Tumor Growth and Progression by Transcriptional Suppression of the E3 Ligase HUWE1 to Stabilize c-Myc. Molecular Cancer Research : McR. PMID 30042175 DOI: 10.1158/1541-7786.MCR-16-0346 |
0.409 |
|
| 2018 |
Grindel BJ, Martinez JR, Tellman TV, Harrington DA, Zafar H, Nakhleh L, Chung LW, Farach-Carson MC. Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells. Scientific Reports. 8: 7262. PMID 29740048 DOI: 10.1038/S41598-018-25435-3 |
0.344 |
|
| 2018 |
Yao N, Jan YJ, Cheng S, Chen JF, Chung LW, Tseng HR, Posadas EM. Structure and function analysis in circulating tumor cells: using nanotechnology to study nuclear size in prostate cancer. American Journal of Clinical and Experimental Urology. 6: 43-54. PMID 29666832 |
0.448 |
|
| 2018 |
Rotinen M, You S, Yang J, Coetzee S, Huang W, Huang F, Pan X, Yáñez A, Hazelett D, Chu C, Chung L, Freedland S, Vizio DD, Garraway I, Murali R, et al. Abstract A047: ONECUT2 is a targetable master regulator of aggressive variants of castration-resistant prostate cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Prca2017-A047 |
0.643 |
|
| 2017 |
Tripathi M, Nandana S, Billet S, Cavassani KA, Mishra R, Chung LWK, Posadas EM, Bhowmick NA. Modulation of cabozantinib efficacy by the prostate tumor microenvironment. Oncotarget. 8: 87891-87902. PMID 29152128 DOI: 10.18632/Oncotarget.21248 |
0.381 |
|
| 2017 |
Ren S, Wei GH, Liu D, Wang L, Hou Y, Zhu S, Peng L, Zhang Q, Cheng Y, Su H, Zhou X, Zhang J, Li F, Zheng H, Zhao Z, ... ... Chung LWK, et al. Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression. European Urology. PMID 28927585 DOI: 10.1016/J.Eururo.2017.08.027 |
0.572 |
|
| 2017 |
Hsieh CL, Liu CM, Chen HA, Yang ST, Shigemura K, Kitagawa K, Yamamichi F, Fujisawa M, Liu YR, Lee WH, Chen KC, Shen CN, Lin CC, Chung LWK, Sung SY. Reactive oxygen species-mediated switching expression of MMP-3 in stromal fibroblasts and cancer cells during prostate cancer progression. Scientific Reports. 7: 9065. PMID 28831065 DOI: 10.1038/s41598-017-08835-9 |
0.587 |
|
| 2017 |
Recouvreux MV, Wu B, Gao AC, Zonis S, Chesnokova V, Bhowmick N, Chung LW, Melmed S. Androgen receptor regulation of local growth hormone in prostate cancer cells. Endocrinology. PMID 28444169 DOI: 10.1210/En.2016-1939 |
0.541 |
|
| 2017 |
Stewart PA, Khamis ZI, Zhau HE, Duan P, Li Q, Chung LWK, Amy Sang QX. Upregulation of minichromosome maintenance complex component 3 during epithelial-to-mesenchymal transition in human prostate cancer. Oncotarget. PMID 28424404 DOI: 10.18632/Oncotarget.16835 |
0.638 |
|
| 2017 |
Wu JB, Yin L, Shi C, Li Q, Duan P, Huang JM, Liu C, Wang F, Lewis M, Wang Y, Lin TP, Pan CC, Posadas EM, Zhau HE, Chung LW. MAOA-Dependent Activation of Shh-IL6-RANKL Signaling Network Promotes Prostate Cancer Metastasis by Engaging Tumor-Stromal Cell Interactions. Cancer Cell. 31: 368-382. PMID 28292438 DOI: 10.1016/J.Ccell.2017.02.003 |
0.393 |
|
| 2017 |
Nandana S, Tripathi M, Duan P, Chu CY, Mishra R, Liu C, Jin R, Yamashita H, Zayzafoon M, Bhowmick NA, Zhau HE, Matusik RJ, Chung LW. Bone metastasis of prostate cancer can be therapeutically targeted at the TBX2-WNT signaling axis. Cancer Research. PMID 28108510 DOI: 10.1158/0008-5472.Can-16-0497 |
0.473 |
|
| 2017 |
Grindel BJ, Harrington DA, Chung L, Farach-Carson MC. Abstract 5944: Matrilysin/MMP-7 compromises a novel border interaction between perlecan/HSPG2 and semaphorin 3A to support prostate cancer invasion Cancer Research. 77: 5944-5944. DOI: 10.1158/1538-7445.Am2017-5944 |
0.544 |
|
| 2016 |
Cheng S, Chen JF, Lu YT, Chung LWK, Tseng HR, Posadas EM. Applications of circulating tumor cells for prostate cancer. Asian Journal of Urology. 3: 254-259. PMID 29264193 DOI: 10.1016/J.Ajur.2016.09.004 |
0.545 |
|
| 2016 |
Li Q, Yin L, Jones LW, Chu GC, Wu JB, Huang JM, Li Q, You S, Kim J, Lu YT, Mrdenovic S, Wang R, Freeman MR, Garraway I, Lewis MS, ... Chung LW, et al. Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells. Oncotarget. PMID 27835867 DOI: 10.18632/Oncotarget.13175 |
0.627 |
|
| 2016 |
Sung SY, Chang JL, Chen KC, Yeh SD, Liu YR, Su YH, Hsueh CY, Chung LW, Hsieh CL. Co-Targeting Prostate Cancer Epithelium and Bone Stroma by Human Osteonectin-Promoter-Mediated Suicide Gene Therapy Effectively Inhibits Androgen-Independent Prostate Cancer Growth. Plos One. 11: e0153350. PMID 27054343 DOI: 10.1371/journal.pone.0153350 |
0.646 |
|
| 2016 |
Li X, Wu JB, Li Q, Shigemura K, Chung LW, Huang WC. SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer. Oncotarget. PMID 26883200 DOI: 10.18632/oncotarget.7331 |
0.489 |
|
| 2016 |
Shiao SL, Chu GC, Chung LW. Regulation of prostate cancer progression by the tumor microenvironment. Cancer Letters. PMID 26828013 DOI: 10.1016/j.canlet.2015.12.022 |
0.469 |
|
| 2016 |
Chen J, Ho H, Hodara E, Ureno A, Go A, Kaufman E, Sievert M, Luthringer DJ, Huang J, Chung L, Ke Z, Li K, Tseng H, Posadas EM. Abstract 4962: Very-small-nuclear circulating tumor cell (vsnCTC) as a putative biomarker for visceral metastasis in metastatic castration-resistant prostate cancer (mCRPC) Cancer Research. 76: 4962-4962. DOI: 10.1158/1538-7445.Am2016-4962 |
0.532 |
|
| 2016 |
Cavassani K, Gururajan M, Sievert M, Duan P, Freeman M, Chu GC, Bhowmick N, Chung L, Posadas E. Abstract 177: Src family kinase Fyn promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer Cancer Research. 76: 177-177. DOI: 10.1158/1538-7445.Am2016-177 |
0.623 |
|
| 2016 |
Chen J, Ho H, Hodara E, Ureno A, Go A, Kaufman E, Sievert M, Luthringer D, Huang J, Li K, Ke Z, Chung L, Tseng H, Posadas E. MP07-06 VERY-SMALL-NUCLEAR CIRCULATING TUMOR CELL (VSNCTC) AS A PUTATIVE BIOMARKER FOR VISCERAL METASTASIS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2209 |
0.492 |
|
| 2015 |
Ziaee S, Chu GC, Huang JM, Sieh S, Chung LW. Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics. Translational Andrology and Urology. 4: 438-54. PMID 26816842 DOI: 10.3978/J.Issn.2223-4683.2015.04.10 |
0.473 |
|
| 2015 |
Josson S, Chung LW, Gururajan M. microRNAs and Prostate Cancer. Advances in Experimental Medicine and Biology. 889: 105-18. PMID 26658999 DOI: 10.1007/978-3-319-23730-5_7 |
0.436 |
|
| 2015 |
Gururajan M, Cavassani KA, Sievert M, Duan P, Lichterman J, Huang JM, Smith B, You S, Nandana S, Chu GC, Mink S, Josson S, Liu C, Morello M, Jones LW, ... ... Chung LW, et al. SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer. Oncotarget. PMID 26624980 DOI: 10.18632/Oncotarget.6398 |
0.522 |
|
| 2015 |
Jiang R, Lu YT, Ho H, Li B, Chen JF, Lin M, Li F, Wu K, Wu H, Lichterman J, Wan H, Lu CL, OuYang W, Ni M, Wang L, ... ... Chung LW, et al. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer. Oncotarget. PMID 26575023 DOI: 10.18632/Oncotarget.6330 |
0.322 |
|
| 2015 |
Li X, Wu JB, Chung LW, Huang WC. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations. Oncotarget. PMID 26512780 DOI: 10.18632/oncotarget.5879 |
0.386 |
|
| 2015 |
Li Q, Li Q, Nuccio J, Liu C, Duan P, Wang R, Jones LW, Chung LW, Zhau HE. Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration-resistant progression and survival of prostate cancer patients. The Prostate. 75: 1312-21. PMID 25990623 DOI: 10.1002/pros.23011 |
0.587 |
|
| 2015 |
Chen JF, Ho H, Lichterman J, Lu YT, Zhang Y, Garcia MA, Chen SF, Liang AJ, Hodara E, Zhau HE, Hou S, Ahmed RS, Luthringer DJ, Huang J, Li KC, ... Chung LW, et al. Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases. Cancer. PMID 25975562 DOI: 10.1002/Cncr.29455 |
0.337 |
|
| 2015 |
Yi X, Yan F, Wang F, Qin W, Wu G, Yang X, Shao C, Chung LW, Yuan J. IR-780 dye for near-infrared fluorescence imaging in prostate cancer. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 21: 511-7. PMID 25686161 DOI: 10.12659/MSM.892437 |
0.56 |
|
| 2015 |
Wu JB, Lin TP, Gallagher JD, Kushal S, Chung LW, Zhau HE, Olenyuk BZ, Shih JC. Monoamine oxidase A inhibitor-near-infrared dye conjugate reduces prostate tumor growth. Journal of the American Chemical Society. 137: 2366-74. PMID 25585152 DOI: 10.1021/Ja512613J |
0.348 |
|
| 2015 |
Yuan J, Yi X, Yan F, Wang F, Qin W, Wu G, Yang X, Shao C, Chung LW. Near‑infrared fluorescence imaging of prostate cancer using heptamethine carbocyanine dyes. Molecular Medicine Reports. 11: 821-8. PMID 25354708 DOI: 10.3892/mmr.2014.2815 |
0.614 |
|
| 2014 |
Nandana S, Chung LW. Prostate cancer progression and metastasis: potential regulatory pathways for therapeutic targeting. American Journal of Clinical and Experimental Urology. 2: 92-101. PMID 25374910 |
0.479 |
|
| 2014 |
Shi C, Wu JB, Chu GC, Li Q, Wang R, Zhang C, Zhang Y, Kim HL, Wang J, Zhau HE, Pan D, Chung LW. Heptamethine carbocyanine dye-mediated near-infrared imaging of canine and human cancers through the HIF-1α/OATPs signaling axis. Oncotarget. 5: 10114-26. PMID 25361418 DOI: 10.18632/ONCOTARGET.2464 |
0.33 |
|
| 2014 |
Gururajan M, Josson S, Chu GC, Lu CL, Lu YT, Haga CL, Zhau HE, Liu C, Lichterman J, Duan P, Posadas EM, Chung LW. miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6559-69. PMID 25324143 DOI: 10.1158/1078-0432.Ccr-14-1784 |
0.338 |
|
| 2014 |
Sung SY, Wu IH, Chuang PH, Petros JA, Wu HC, Zeng HJ, Huang WC, Chung LW, Hsieh CL. Targeting L1 cell adhesion molecule expression using liposome-encapsulated siRNA suppresses prostate cancer bone metastasis and growth. Oncotarget. 5: 9911-29. PMID 25294816 |
0.633 |
|
| 2014 |
Ziaee S, Chung LW. Induction of integrin α2 in a highly bone metastatic human prostate cancer cell line: roles of RANKL and AR under three-dimensional suspension culture. Molecular Cancer. 13: 208. PMID 25200184 DOI: 10.1186/1476-4598-13-208 |
0.428 |
|
| 2014 |
Josson S, Gururajan M, Hu P, Shao C, Chu GY, Zhau HE, Liu C, Lao K, Lu CL, Lu YT, Lichterman J, Nandana S, Li Q, Rogatko A, Berel D, ... ... Chung LW, et al. miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4636-46. PMID 24963047 DOI: 10.1158/1078-0432.Ccr-14-0305 |
0.445 |
|
| 2014 |
Wu JB, Shao C, Li X, Li Q, Hu P, Shi C, Li Y, Chen YT, Yin F, Liao CP, Stiles BL, Zhau HE, Shih JC, Chung LW. Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis. The Journal of Clinical Investigation. 124: 2891-908. PMID 24865426 DOI: 10.1172/Jci70982 |
0.585 |
|
| 2014 |
Shao C, Liao CP, Hu P, Chu CY, Zhang L, Bui MH, Ng CS, Josephson DY, Knudsen B, Tighiouart M, Kim HL, Zhau HE, Chung LW, Wang R, Posadas EM. Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer. Plos One. 9: e88967. PMID 24551200 DOI: 10.1371/journal.pone.0088967 |
0.385 |
|
| 2014 |
Chu GC, Zhau HE, Wang R, Rogatko A, Feng X, Zayzafoon M, Liu Y, Farach-Carson MC, You S, Kim J, Freeman MR, Chung LW. RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization. Endocrine-Related Cancer. 21: 311-26. PMID 24478054 DOI: 10.1530/Erc-13-0548 |
0.442 |
|
| 2014 |
Chu GC, Chung LW. RANK-mediated signaling network and cancer metastasis. Cancer Metastasis Reviews. 33: 497-509. PMID 24398859 DOI: 10.1007/s10555-013-9488-7 |
0.598 |
|
| 2014 |
Nomura T, Huang WC, Zhau HE, Josson S, Mimata H, Chung LW. β2-Microglobulin-mediated signaling as a target for cancer therapy. Anti-Cancer Agents in Medicinal Chemistry. 14: 343-52. PMID 23848204 DOI: 10.2174/18715206113139990092 |
0.332 |
|
| 2013 |
Wu J, Pan D, Chung LW. Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer. Translational Andrology and Urology. 2: 254-264. PMID 25285271 DOI: 10.3978/j.issn.2223-4683.2013.09.05 |
0.449 |
|
| 2013 |
Morello M, Minciacchi VR, de Candia P, Yang J, Posadas E, Kim H, Griffiths D, Bhowmick N, Chung LW, Gandellini P, Freeman MR, Demichelis F, Di Vizio D. Large oncosomes mediate intercellular transfer of functional microRNA. Cell Cycle (Georgetown, Tex.). 12: 3526-36. PMID 24091630 DOI: 10.4161/Cc.26539 |
0.42 |
|
| 2013 |
Hu P, Chung LW, Berel D, Frierson HF, Yang H, Liu C, Wang R, Li Q, Rogatko A, Zhau HE. Convergent RANK- and c-Met-mediated signaling components predict survival of patients with prostate cancer: an interracial comparative study. Plos One. 8: e73081. PMID 24066029 DOI: 10.1371/journal.pone.0073081 |
0.366 |
|
| 2013 |
Josson S, Matsuoka Y, Gururajan M, Nomura T, Huang WC, Yang X, Lin JT, Bridgman R, Chu CY, Johnstone PA, Zayzafoon M, Hu P, Zhau H, Berel D, Rogatko A, ... Chung LW, et al. Inhibition of β2-microglobulin/hemochromatosis enhances radiation sensitivity by induction of iron overload in prostate cancer cells. Plos One. 8: e68366. PMID 23874600 DOI: 10.1371/Journal.Pone.0068366 |
0.487 |
|
| 2013 |
Zhau HE, Li Q, Chung LW. Interracial differences in prostate cancer progression among patients from the United States, China and Japan. Asian Journal of Andrology. 15: 705-7. PMID 23872663 DOI: 10.1038/aja.2013.86 |
0.551 |
|
| 2013 |
Lu YT, Zhao L, Shen Q, Garcia MA, Wu D, Hou S, Song M, Xu X, Ouyang WH, Ouyang WW, Lichterman J, Luo Z, Xuan X, Huang J, Chung LW, et al. NanoVelcro Chip for CTC enumeration in prostate cancer patients. Methods (San Diego, Calif.). 64: 144-52. PMID 23816790 DOI: 10.1016/J.Ymeth.2013.06.019 |
0.498 |
|
| 2013 |
Zhao L, Lu YT, Li F, Wu K, Hou S, Yu J, Shen Q, Wu D, Song M, OuYang WH, Luo Z, Lee T, Fang X, Shao C, Xu X, ... ... Chung LW, et al. High-purity prostate circulating tumor cell isolation by a polymer nanofiber-embedded microchip for whole exome sequencing. Advanced Materials (Deerfield Beach, Fla.). 25: 2897-902. PMID 23529932 DOI: 10.1002/Adma.201205237 |
0.488 |
|
| 2013 |
Qi J, Tripathi M, Mishra R, Sahgal N, Fazli L, Fazil L, Ettinger S, Placzek WJ, Claps G, Chung LW, Bowtell D, Gleave M, Bhowmick N, Ronai ZA. The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity. Cancer Cell. 23: 332-46. PMID 23518348 DOI: 10.1016/j.ccr.2013.02.016 |
0.646 |
|
| 2013 |
Liu CM, Hsieh CL, He YC, Lo SJ, Liang JA, Hsieh TF, Josson S, Chung LW, Hung MC, Sung SY. In vivo targeting of ADAM9 gene expression using lentivirus-delivered shRNA suppresses prostate cancer growth by regulating REG4 dependent cell cycle progression. Plos One. 8: e53795. PMID 23342005 DOI: 10.1371/Journal.Pone.0053795 |
0.621 |
|
| 2013 |
Zhang S, Wang X, Iqbal S, Wang Y, Osunkoya AO, Chen Z, Chen Z, Shin DM, Yuan H, Wang YA, Zhau HE, Chung LW, Ritenour C, Kucuk O, Wu D. Epidermal growth factor promotes protein degradation of epithelial protein lost in neoplasm (EPLIN), a putative metastasis suppressor, during epithelial-mesenchymal transition. The Journal of Biological Chemistry. 288: 1469-79. PMID 23188829 DOI: 10.1074/Jbc.M112.438341 |
0.35 |
|
| 2013 |
Chung LW. LNCaP human prostate cancer progression model. Urologic Oncology. 2: 126-8. PMID 21224154 DOI: 10.1016/S1078-1439(97)82846-3 |
0.605 |
|
| 2013 |
Fatma M, Shigemura K, Behnsawy H, Yamamichi F, Haung W, Li X, Chung L, Yamashita M, Fujisawa M, Kawabata M, Shirakawa T. 970 Sonic Hedgehog Signaling And Androgens Are Linked In Tumor-Stromal Interaction Through Epithelial-Mesenchymal Transition (Emt) In Prostate Cancer Progression The Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1069 |
0.604 |
|
| 2012 |
Pen CC, Liu CM, Lin CC, Lin CC, Hsieh TF, Josson S, He YC, Chung LW, Lin KL, Sung SY. Combined Dynamic Alterations in Urinary VEGF Levels and Tissue ADAM9 Expression as Markers for Lethal Phenotypic Progression of Prostate Cancer. The Chinese Journal of Physiology. 55: 390-7. PMID 23286446 DOI: 10.4077/Cjp.2012.Baa075 |
0.541 |
|
| 2012 |
Jackson RS, Placzek W, Fernandez A, Ziaee S, Chu CY, Wei J, Stebbins J, Kitada S, Fritz G, Reed JC, Chung LW, Pellecchia M, Bhowmick NA. Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer. Neoplasia (New York, N.Y.). 14: 656-65. PMID 22904682 DOI: 10.1593/Neo.12640 |
0.615 |
|
| 2012 |
Wang R, Sun X, Wang CY, Hu P, Chu CY, Liu S, Zhau HE, Chung LW. Spontaneous cancer-stromal cell fusion as a mechanism of prostate cancer androgen-independent progression. Plos One. 7: e42653. PMID 22880071 DOI: 10.1371/journal.pone.0042653 |
0.529 |
|
| 2012 |
Gururajan M, Posadas EM, Chung LW. Future perspectives of prostate cancer therapy. Translational Andrology and Urology. 1: 19-32. PMID 22773967 DOI: 10.3978/j.issn.2223-4683.2012.01.03 |
0.559 |
|
| 2012 |
Iqbal S, Zhang S, Driss A, Liu ZR, Kim HR, Wang Y, Ritenour C, Zhau HE, Kucuk O, Chung LW, Wu D. PDGF upregulates Mcl-1 through activation of β-catenin and HIF-1α-dependent signaling in human prostate cancer cells. Plos One. 7: e30764. PMID 22276222 DOI: 10.1371/journal.pone.0030764 |
0.514 |
|
| 2012 |
Huang WC, Li X, Liu J, Lin J, Chung LW. Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells. Molecular Cancer Research : McR. 10: 133-42. PMID 22064655 DOI: 10.1158/1541-7786.Mcr-11-0206 |
0.643 |
|
| 2012 |
Koochekpour S, Hu S, Vellasco-Gonzalez C, Bernardo R, Azabdaftari G, Zhu G, Zhau HE, Chung LW, Vessella RL. Serum prosaposin levels are increased in patients with advanced prostate cancer. The Prostate. 72: 253-69. PMID 21630292 DOI: 10.1002/pros.21427 |
0.482 |
|
| 2012 |
Zhau HE, Zhao LS, Chung LW, Chen BQ, Troncoso P, Kao C, Kojima M, Fraser Symmans W, Zheng N, Palmer JL, Moul JW, Davis R, Ye MF, Xiao LS, Craig Hall M. Comparative studies of prostate cancers among United States, Chinese, and Japanese patients: characterization of histopathology, tumor angiogenesis, neuroendocrine factors, and p53 protein accumulations. Urologic Oncology. 1: 51-63. PMID 21224092 DOI: 10.1016/1078-1439(95)00009-7 |
0.55 |
|
| 2012 |
Shigemura K, Meligy F, Behnsawy H, Yamamichi F, Haung W, Li X, Chung L, Yamanaka K, Hanioka K, Yamashita M, Shirakawa T, Tanaka K, Arakawa S, Fujisawa M. Abstract 1407: Sonic hedgehog signaling and Androgens are linked in tumor-stromal interaction through Epithelial-Mesenchymal transition (EMT) in prostate cancer progression Cancer Research. 72: 1407-1407. DOI: 10.1158/1538-7445.Am2012-1407 |
0.648 |
|
| 2012 |
Meligy F, Shigemura K, Behnsawy H, Yamamichi F, Yamashita M, Haung W, Xiangyan L, Chung L, Fujisawa M, Kawabata M, Shirakawa T. 146 Possible Role Of Sonic Hedgehog Signaling And The Link With Epithelial-Mesenchymal Transition (Emt) In Renal Cancer Progression The Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.196 |
0.32 |
|
| 2011 |
Hu P, Chu GC, Zhu G, Yang H, Luthringer D, Prins G, Habib F, Wang Y, Wang R, Chung LW, Zhau HE. Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer. Plos One. 6: e28670. PMID 22205960 DOI: 10.1371/journal.pone.0028670 |
0.56 |
|
| 2011 |
Lue HW, Yang X, Wang R, Qian W, Xu RZ, Lyles R, Osunkoya AO, Zhou BP, Vessella RL, Zayzafoon M, Liu ZR, Zhau HE, Chung LW. LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling. Plos One. 6: e27720. PMID 22110740 DOI: 10.1371/Journal.Pone.0027720 |
0.637 |
|
| 2011 |
Wang X, Stewart PA, Cao Q, Sang QX, Chung LW, Emmett MR, Marshall AG. Characterization of the phosphoproteome in androgen-repressed human prostate cancer cells by Fourier transform ion cyclotron resonance mass spectrometry. Journal of Proteome Research. 10: 3920-8. PMID 21786837 DOI: 10.1021/Pr2000144 |
0.341 |
|
| 2011 |
Shigemura K, Huang WC, Li X, Zhau HE, Zhu G, Gotoh A, Fujisawa M, Xie J, Marshall FF, Chung LW. Active sonic hedgehog signaling between androgen independent human prostate cancer cells and normal/benign but not cancer-associated prostate stromal cells. The Prostate. 71: 1711-22. PMID 21520153 DOI: 10.1002/pros.21388 |
0.669 |
|
| 2011 |
Josson S, Nomura T, Lin JT, Huang WC, Wu D, Zhau HE, Zayzafoon M, Weizmann MN, Gururajan M, Chung LW. β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells. Cancer Research. 71: 2600-10. PMID 21427356 DOI: 10.1158/0008-5472.Can-10-3382 |
0.359 |
|
| 2011 |
Zhang D, He D, Xue Y, Wang R, Wu K, Xie H, Zeng J, Wang X, Zhau HE, Chung LW, Chang LS, Li L. PrLZ protects prostate cancer cells from apoptosis induced by androgen deprivation via the activation of Stat3/Bcl-2 pathway. Cancer Research. 71: 2193-202. PMID 21385902 DOI: 10.1158/0008-5472.CAN-10-1791 |
0.668 |
|
| 2011 |
Zhau HE, He H, Wang CY, Zayzafoon M, Morrissey C, Vessella RL, Marshall FF, Chung LW, Wang R. Human prostate cancer harbors the stem cell properties of bone marrow mesenchymal stem cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 2159-69. PMID 21355075 DOI: 10.1158/1078-0432.Ccr-10-2523 |
0.576 |
|
| 2011 |
Barnett P, Arnold RS, Mezencev R, Chung LW, Zayzafoon M, Odero-Marah V. Snail-mediated regulation of reactive oxygen species in ARCaP human prostate cancer cells. Biochemical and Biophysical Research Communications. 404: 34-9. PMID 21093414 DOI: 10.1016/J.Bbrc.2010.11.044 |
0.467 |
|
| 2011 |
Josson S, Anderson CS, Sung SY, Johnstone PA, Kubo H, Hsieh CL, Arnold R, Gururajan M, Yates C, Chung LW. Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy. The Prostate. 71: 232-40. PMID 20672324 DOI: 10.1002/Pros.21237 |
0.534 |
|
| 2011 |
Zhang C, Soori M, Miles FL, Sikes RA, Carson DD, Chung LW, Farach-Carson MC. Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells. The Prostate. 71: 157-67. PMID 20665531 DOI: 10.1002/Pros.21231 |
0.36 |
|
| 2011 |
Li Y, Sikes RA, Malaeb BS, Yeung F, Law A, Graham SE, Pei M, Kao C, Nelson J, Koeneman KS, Chung LW. Osteoblasts can stimulate prostate cancer growth and transcriptionally down-regulate PSA expression in cell line models. Urologic Oncology. 29: 802-8. PMID 20451417 DOI: 10.1016/J.Urolonc.2009.09.016 |
0.805 |
|
| 2011 |
Shigemura K, Haung W, Zhau H, Li X, Yamashita M, Gotoh A, Arakawa S, Chung L, Fujisawa M. Abstract 521: Active sonic hedgehog signaling between androgen independent human prostate cancer cells and normal/benign but not cancer-associated prostate stromal cells Cancer Research. 71: 521-521. DOI: 10.1158/1538-7445.Am2011-521 |
0.728 |
|
| 2011 |
Collak FK, Luthringer D, Kim HL, Chung L, Cinar B. Abstract 2928: Regulation of MST1 and MST2 by mTOR and androgen receptor signaling in prostate cancer Cancer Research. 71: 2928-2928. DOI: 10.1158/1538-7445.Am2011-2928 |
0.555 |
|
| 2011 |
Koochekpour S, Hu S, Velasco-Gonzalez C, Badri ME, Bernardo R, Zieske A, Azabdaftari G, Chung L, Zhau H, Vessella R, Garai J. 2334 Prosaposin, A Novel Biomarker For Primary And Metastatic Prostate Cancer The Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.2581 |
0.662 |
|
| 2010 |
Josson S, Sharp S, Sung SY, Johnstone PA, Aneja R, Wang R, Gururajan M, Turner T, Chung LW, Yates C. Tumor-Stromal Interactions Influence Radiation Sensitivity in Epithelial- versus Mesenchymal-Like Prostate Cancer Cells. Journal of Oncology. 2010. PMID 20798867 DOI: 10.1155/2010/232831 |
0.443 |
|
| 2010 |
Sun X, He H, Xie Z, Qian W, Zhau HE, Chung LW, Marshall FF, Wang R. Matched pairs of human prostate stromal cells display differential tropic effects on LNCaP prostate cancer cells. In Vitro Cellular & Developmental Biology. Animal. 46: 538-46. PMID 20383666 DOI: 10.1007/s11626-010-9309-z |
0.67 |
|
| 2010 |
He H, Davidson AJ, Wu D, Marshall FF, Chung LW, Zhau HE, He D, Wang R. Phorbol ester phorbol-12-myristate-13-acetate induces epithelial to mesenchymal transition in human prostate cancer ARCaPE cells. The Prostate. 70: 1119-26. PMID 20333698 DOI: 10.1002/pros.21146 |
0.463 |
|
| 2010 |
Aneja R, Miyagi T, Karna P, Ezell T, Shukla D, Vij Gupta M, Yates C, Chinni SR, Zhau H, Chung LW, Joshi HC. A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells. European Journal of Cancer (Oxford, England : 1990). 46: 1668-78. PMID 20303260 DOI: 10.1016/J.Ejca.2010.02.017 |
0.548 |
|
| 2010 |
McKeithen D, Graham T, Chung LW, Odero-Marah V. Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells. The Prostate. 70: 982-92. PMID 20166136 DOI: 10.1002/Pros.21132 |
0.437 |
|
| 2010 |
He H, Xu J, Nelson PS, Marshall FF, Chung LW, Zhau HE, He D, Wang R. Differential expression of the alpha2 chain of the interleukin-13 receptor in metastatic human prostate cancer ARCaPM cells. The Prostate. 70: 993-1001. PMID 20166133 DOI: 10.1002/pros.21133 |
0.547 |
|
| 2010 |
Zhang S, Zhau HE, Osunkoya AO, Iqbal S, Yang X, Fan S, Chen Z, Wang R, Marshall FF, Chung LW, Wu D. Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells. Molecular Cancer. 9: 9. PMID 20085644 DOI: 10.1186/1476-4598-9-9 |
0.469 |
|
| 2010 |
Huang WC, Zhau HE, Chung LW. Androgen receptor survival signaling is blocked by anti-beta2-microglobulin monoclonal antibody via a MAPK/lipogenic pathway in human prostate cancer cells. The Journal of Biological Chemistry. 285: 7947-56. PMID 20071336 DOI: 10.1074/jbc.M109.092759 |
0.575 |
|
| 2010 |
Josson S, Matsuoka Y, Chung LW, Zhau HE, Wang R. Tumor-stroma co-evolution in prostate cancer progression and metastasis. Seminars in Cell & Developmental Biology. 21: 26-32. PMID 19948237 DOI: 10.1016/J.Semcdb.2009.11.016 |
0.458 |
|
| 2010 |
He H, Yang X, Davidson AJ, Wu D, Marshall FF, Chung LW, Zhau HE, Wang R. Progressive epithelial to mesenchymal transitions in ARCaP E prostate cancer cells during xenograft tumor formation and metastasis. The Prostate. 70: 518-28. PMID 19918799 DOI: 10.1002/pros.21086 |
0.368 |
|
| 2010 |
Thalmann GN, Rhee H, Sikes RA, Pathak S, Multani A, Zhau HE, Marshall FF, Chung LW. Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP Cells. European Urology. 58: 162-71. PMID 19747763 DOI: 10.1016/J.Eururo.2009.08.026 |
0.61 |
|
| 2010 |
Jen-Tai L, Josson S, Huang W, Zhau H, Chung L. 1188 EPITHELIAL TO MESENCHYMAL TRANSITION (EMT) AND ITS REVERSAL CAN BE PROVOKED BY IRON-MEDIATED OXIDATIVE STRESS SIGNALING IN HUMAN PROSTATE CANCER CELLS Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.689 |
0.531 |
|
| 2010 |
Matsuoka Y, Josson S, Gururajan M, Yang X, Chung L. 239 RADIATION SENSITIZATION BY A CYTOTOXIC ANTI-β2-MICROGLOBULIN ANTIBODY FOR THE TREATMENT OF PROSTATE CANCER IN EXPERIMENTAL MODELS Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.297 |
0.507 |
|
| 2010 |
Arnold R, Osunkoya A, Chung L, True L, Petros J. 223 MITOCHONDRIAL DNA MUTATIONS INCREASE WITH METASTASIS IN PROSTATE CANCER Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.281 |
0.54 |
|
| 2009 |
Wang R, He H, Sun X, Xu J, Marshall FF, Zhau H, Chung LW, Fu H, He D. Transcription variants of the prostate-specific PrLZ gene and their interaction with 14-3-3 proteins. Biochemical and Biophysical Research Communications. 389: 455-60. PMID 19732746 DOI: 10.1016/J.Bbrc.2009.08.165 |
0.626 |
|
| 2009 |
Singh S, Singh R, Singh UP, Rai SN, Novakovic KR, Chung LW, Didier PJ, Grizzle WE, Lillard JW. Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines. International Journal of Cancer. Journal International Du Cancer. 125: 2288-95. PMID 19610059 DOI: 10.1002/Ijc.24574 |
0.471 |
|
| 2009 |
Shi C, Zhu Y, Xie Z, Qian W, Hsieh CL, Nie S, Su Y, Zhau HE, Chung LW. Visualizing human prostate cancer cells in mouse skeleton using bioconjugated near-infrared fluorescent quantum dots. Urology. 74: 446-51. PMID 19428067 DOI: 10.1016/J.Urology.2009.01.023 |
0.427 |
|
| 2009 |
Singh S, Singh R, Sharma PK, Singh UP, Rai SN, Chung LW, Cooper CR, Novakovic KR, Grizzle WE, Lillard JW. Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion. Cancer Letters. 283: 29-35. PMID 19375853 DOI: 10.1016/J.Canlet.2009.03.022 |
0.595 |
|
| 2009 |
Shigemura K, Isotani S, Wang R, Fujisawa M, Gotoh A, Marshall FF, Zhau HE, Chung LW. Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase. The Prostate. 69: 949-55. PMID 19274665 DOI: 10.1002/pros.20944 |
0.589 |
|
| 2009 |
Shi C, Zhu Y, Su Y, Chung LW, Cheng T. Beta2-microglobulin: emerging as a promising cancer therapeutic target. Drug Discovery Today. 14: 25-30. PMID 19056512 DOI: 10.1016/j.drudis.2008.11.001 |
0.329 |
|
| 2009 |
Graham TR, Odero-Marah VA, Chung LW, Agrawal KC, Davis R, Abdel-Mageed AB. PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells. The Prostate. 69: 168-80. PMID 18942118 DOI: 10.1002/Pros.20870 |
0.562 |
|
| 2009 |
Arnold RS, Sun CQ, Richards JC, Grigoriev G, Coleman IM, Nelson PS, Hsieh CL, Lee JK, Xu Z, Rogatko A, Osunkoya AO, Zayzafoon M, Chung L, Petros JA. Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment. The Prostate. 69: 1-11. PMID 18850577 DOI: 10.1002/Pros.20854 |
0.582 |
|
| 2008 |
Sung SY, Hsieh CL, Law A, Zhau HE, Pathak S, Multani AS, Lim S, Coleman IM, Wu LC, Figg WD, Dahut WL, Nelson P, Lee JK, Amin MB, Lyles R, ... ... Chung LW, et al. Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis. Cancer Research. 68: 9996-10003. PMID 19047182 DOI: 10.1158/0008-5472.Can-08-2492 |
0.581 |
|
| 2008 |
Seo SI, Gera L, Zhau HE, Qian WP, Iqbal S, Johnson NA, Zhang S, Zayzafoon M, Stewart J, Wang R, Chung LW, Wu D. BKM1740, an acyl-tyrosine bisphosphonate amide derivative, inhibits the bone metastatic growth of human prostate cancer cells by inducing apoptosis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 6198-206. PMID 18829499 DOI: 10.1158/1078-0432.Ccr-08-1023 |
0.417 |
|
| 2008 |
Huang WC, Havel JJ, Zhau HE, Qian WP, Lue HW, Chu CY, Nomura T, Chung LW. Beta2-microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 5341-7. PMID 18765525 DOI: 10.1158/1078-0432.Ccr-08-0793 |
0.579 |
|
| 2008 |
Josson S, Sung SY, Lao K, Chung LW, Johnstone PA. Radiation modulation of microRNA in prostate cancer cell lines. The Prostate. 68: 1599-606. PMID 18668526 DOI: 10.1002/Pros.20827 |
0.371 |
|
| 2008 |
Odero-Marah VA, Wang R, Chu G, Zayzafoon M, Xu J, Shi C, Marshall FF, Zhau HE, Chung LW. Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells. Cell Research. 18: 858-70. PMID 18645583 DOI: 10.1038/Cr.2008.84 |
0.549 |
|
| 2008 |
Shi C, Zhou G, Zhu Y, Su Y, Cheng T, Zhau HE, Chung LW. Quantum dots-based multiplexed immunohistochemistry of protein expression in human prostate cancer cells. European Journal of Histochemistry : Ejh. 52: 127-34. PMID 18591159 DOI: 10.4081/1202 |
0.499 |
|
| 2008 |
Zhau HE, Odero-Marah V, Lue HW, Nomura T, Wang R, Chu G, Liu ZR, Zhou BP, Huang WC, Chung LW. Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model. Clinical & Experimental Metastasis. 25: 601-10. PMID 18535913 DOI: 10.1007/S10585-008-9183-1 |
0.555 |
|
| 2008 |
Pienta KJ, Abate-Shen C, Agus DB, Attar RM, Chung LW, Greenberg NM, Hahn WC, Isaacs JT, Navone NM, Peehl DM, Simons JW, Solit DB, Soule HR, VanDyke TA, Weber MJ, et al. The current state of preclinical prostate cancer animal models. The Prostate. 68: 629-39. PMID 18213636 DOI: 10.1002/Pros.20726 |
0.571 |
|
| 2007 |
Shirakawa T, Terao S, Hinata N, Tanaka K, Takenaka A, Hara I, Sugimura K, Matsuo M, Hamada K, Fuji K, Okegawa T, Higashihara E, Gardner TA, Kao C, Chung LW, et al. Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer. Human Gene Therapy. 18: 1225-32. PMID 18021019 DOI: 10.1089/Hum.2007.074 |
0.415 |
|
| 2007 |
Wang R, Xu J, Mabjeesh N, Zhu G, Zhou J, Amin M, He D, Marshall FF, Zhau HE, Chung LW. PrLZ is expressed in normal prostate development and in human prostate cancer progression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 6040-8. PMID 17947466 DOI: 10.1158/1078-0432.CCR-07-0640 |
0.635 |
|
| 2007 |
Zhang H, Wang J, Pang B, Liang RX, Li S, Huang PT, Wang R, Chung LW, Zhau HE, Huang C, Zhou JG. PC-1/PrLZ contributes to malignant progression in prostate cancer. Cancer Research. 67: 8906-13. PMID 17875733 DOI: 10.1158/0008-5472.Can-06-4214 |
0.666 |
|
| 2007 |
Mukhopadhyay NK, Cinar B, Mukhopadhyay L, Lutchman M, Ferdinand AS, Kim J, Chung LW, Adam RM, Ray SK, Leiter AB, Richie JP, Liu BC, Freeman MR. The zinc finger protein ras-responsive element binding protein-1 is a coregulator of the androgen receptor: implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer. Molecular Endocrinology (Baltimore, Md.). 21: 2056-70. PMID 17550981 DOI: 10.1210/Me.2006-0503 |
0.606 |
|
| 2007 |
Hsieh CL, Xie Z, Yu J, Martin WD, Datta MW, Wu GJ, Chung LW. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model. The Prostate. 67: 685-91. PMID 17342752 DOI: 10.1002/pros.20510 |
0.591 |
|
| 2007 |
Shigemura K, Sung SY, Kubo H, Arnold RS, Fujisawa M, Gotoh A, Zhau HE, Chung LW. Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells. The Prostate. 67: 722-31. PMID 17342749 DOI: 10.1002/pros.20565 |
0.568 |
|
| 2007 |
Shigemura K, Arbiser JL, Sun SY, Zayzafoon M, Johnstone PA, Fujisawa M, Gotoh A, Weksler B, Zhau HE, Chung LW. Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer. 109: 1279-89. PMID 17326044 DOI: 10.1002/Cncr.22551 |
0.528 |
|
| 2007 |
Gao X, Chung LW, Nie S. Quantum dots for in vivo molecular and cellular imaging. Methods in Molecular Biology (Clifton, N.J.). 374: 135-45. PMID 17237536 DOI: 10.1385/1-59745-369-2:135 |
0.327 |
|
| 2007 |
Xing Y, Numora T, Chung L, Zhau H, Nie S. Multiplexed molecular profiling of prostate cancer specimens using semiconductor quantum dot bioconjugates Proceedings of Spie. 6448: 644810. DOI: 10.1117/12.714790 |
0.478 |
|
| 2006 |
Zhu GD, He DL, He H, Zhang LL, Wang XY, Zhau EH, Chung LWK. Expression patterns of sonic hedgehog signaling molecules in human fetal prostate development Zhonghua Nan Ke Xue = National Journal of Andrology. 12: 896-899. PMID 17121018 |
0.521 |
|
| 2006 |
Chung LW, Huang WC, Sung SY, Wu D, Odero-Marah V, Nomura T, Shigemura K, Miyagi T, Seo S, Shi C, Molitierno J, Elmore J, Anderson C, Isotani S, Edlund M, et al. Stromal-epithelial interaction in prostate cancer progression. Clinical Genitourinary Cancer. 5: 162-70. PMID 17026806 DOI: 10.3816/Cgc.2006.N.034 |
0.465 |
|
| 2006 |
Sung SY, Kubo H, Shigemura K, Arnold RS, Logani S, Wang R, Konaka H, Nakagawa M, Mousses S, Amin M, Anderson C, Johnstone P, Petros JA, Marshall FF, Zhau HE, ... Chung LW, et al. Oxidative stress induces ADAM9 protein expression in human prostate cancer cells. Cancer Research. 66: 9519-26. PMID 17018608 DOI: 10.1158/0008-5472.CAN-05-4375 |
0.593 |
|
| 2006 |
Huang WC, Wu D, Xie Z, Zhau HE, Nomura T, Zayzafoon M, Pohl J, Hsieh CL, Weitzmann MN, Farach-Carson MC, Chung LW. beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis. Cancer Research. 66: 9108-16. PMID 16982753 DOI: 10.1158/0008-5472.Can-06-1996 |
0.591 |
|
| 2006 |
Luo Y, He DL, Ning L, Shen SL, Li L, Li X, Zhau HE, Chung LW. Over-expression of hypoxia-inducible factor-1alpha increases the invasive potency of LNCaP cells in vitro. Bju International. 98: 1315-9. PMID 16956360 DOI: 10.1111/j.1464-410X.2006.06480.x |
0.436 |
|
| 2006 |
Xu J, Wang R, Xie ZH, Odero-Marah V, Pathak S, Multani A, Chung LW, Zhau HE. Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis. The Prostate. 66: 1664-73. PMID 16902972 DOI: 10.1002/Pros.20488 |
0.528 |
|
| 2006 |
Tate A, Isotani S, Bradley MJ, Sikes RA, Davis R, Chung LW, Edlund M. Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells. Bmc Cancer. 6: 197. PMID 16869958 DOI: 10.1186/1471-2407-6-197 |
0.622 |
|
| 2006 |
Dong XY, Chen C, Sun X, Guo P, Vessella RL, Wang RX, Chung LW, Zhou W, Dong JT. FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. Cancer Research. 66: 6998-7006. PMID 16849544 DOI: 10.1158/0008-5472.Can-06-0411 |
0.566 |
|
| 2006 |
Muir C, Chung LW, Carson DD, Farach-Carson MC. Hypoxia increases VEGF-A production by prostate cancer and bone marrow stromal cells and initiates paracrine activation of bone marrow endothelial cells. Clinical & Experimental Metastasis. 23: 75-86. PMID 16826426 DOI: 10.1007/S10585-006-9021-2 |
0.374 |
|
| 2006 |
Cher ML, Towler DA, Rafii S, Rowley D, Donahue HJ, Keller E, Herlyn M, Cho EA, Chung LW. Cancer interaction with the bone microenvironment: a workshop of the National Institutes of Health Tumor Microenvironment Study Section. The American Journal of Pathology. 168: 1405-12. PMID 16651608 DOI: 10.2353/Ajpath.2006.050874 |
0.304 |
|
| 2005 |
Savorè C, Zhang C, Muir C, Liu R, Wyrwa J, Shu J, Zhau HE, Chung LW, Carson DD, Farach-Carson MC. Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo. Clinical & Experimental Metastasis. 22: 377-90. PMID 16283481 DOI: 10.1007/S10585-005-2339-3 |
0.484 |
|
| 2005 |
Malaeb BS, Gardner TA, Margulis V, Yang L, Gillenwater JY, Chung LW, Macik G, Koeneman KS. Elevated activated partial thromboplastin time during administration of first-generation adenoviral vectors for gene therapy for prostate cancer: identification of lupus anticoagulants. Urology. 66: 830-4. PMID 16230147 DOI: 10.1016/j.urology.2005.04.041 |
0.518 |
|
| 2005 |
Hsieh CL, Xie Z, Liu ZY, Green JE, Martin WD, Datta MW, Yeung F, Pan D, Chung LW. A luciferase transgenic mouse model: visualization of prostate development and its androgen responsiveness in live animals. Journal of Molecular Endocrinology. 35: 293-304. PMID 16216910 DOI: 10.1677/jme.1.01722 |
0.801 |
|
| 2005 |
Bisanz K, Yu J, Edlund M, Spohn B, Hung MC, Chung LW, Hsieh CL. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 634-43. PMID 16039164 DOI: 10.1016/j.ymthe.2005.05.012 |
0.585 |
|
| 2005 |
Wang R, Xu J, Juliette L, Castilleja A, Love J, Sung SY, Zhau HE, Goodwin TJ, Chung LW. Three-dimensional co-culture models to study prostate cancer growth, progression, and metastasis to bone. Seminars in Cancer Biology. 15: 353-64. PMID 15982899 DOI: 10.1016/j.semcancer.2005.05.005 |
0.525 |
|
| 2005 |
Huang WC, Xie Z, Konaka H, Sodek J, Zhau HE, Chung LW. Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: role of cAMP-dependent protein kinase A signaling pathway. Cancer Research. 65: 2303-13. PMID 15781644 DOI: 10.1158/0008-5472.Can-04-3448 |
0.532 |
|
| 2005 |
Chung LW, Baseman A, Assikis V, Zhau HE. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. The Journal of Urology. 173: 10-20. PMID 15592017 DOI: 10.1097/01.JU.0000141582.15218.10 |
0.504 |
|
| 2005 |
Jin F, Xie Z, Kuo CJ, Chung LW, Hsieh CL. Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy. Cancer Gene Therapy. 12: 257-67. PMID 15565180 DOI: 10.1038/sj.cgt.7700790 |
0.491 |
|
| 2005 |
Lim SD, Sun C, Lambeth JD, Marshall F, Amin M, Chung L, Petros JA, Arnold RS. Increased Nox1 and hydrogen peroxide in prostate cancer. The Prostate. 62: 200-7. PMID 15389790 DOI: 10.1002/Pros.20137 |
0.539 |
|
| 2004 |
Chung LWK. The roles of myofibroblasts in prostate carcinogenesis Journal of Urology. 172: 2125-2126. PMID 15538214 DOI: 10.1097/01.ju.0000145136.48668.41 |
0.598 |
|
| 2004 |
Sokoloff MH, Rinker-Schaeffer CW, Chung LW, Brendler CB. Adjunctive therapy for men with high risk localized and locally advanced prostate cancer: targeting disseminated tumor cells. The Journal of Urology. 172: 2539-44. PMID 15538203 DOI: 10.1097/01.JU.0000145044.97177.09 |
0.411 |
|
| 2004 |
Andriole G, Bruchovsky N, Chung LWK, Matsumoto AM, Rittmaster R, Roehrborn C, Russell D, Tindall D. Dihydrotestosterone and the prostate: The scientific rationale for 5α-reductase inhibitors in the treatment of benign prostatic hyperplasia Journal of Urology. 172: 1399-1403. PMID 15371854 DOI: 10.1097/01.Ju.0000139539.94828.29 |
0.506 |
|
| 2004 |
Sikes RA, Nicholson BE, Koeneman KS, Edlund NM, Bissonette EA, Bradley MJ, Thalmann GN, Cecchini MG, Pienta KJ, Chung LW. Cellular interactions in the tropism of prostate cancer to bone. International Journal of Cancer. Journal International Du Cancer. 110: 497-503. PMID 15122581 DOI: 10.1002/Ijc.20153 |
0.49 |
|
| 2004 |
He D, Wang M, Chen X, Gao Z, He H, Zhau HE, Wang W, Chung LW, Nan X. Ethnic differences in distribution of serum prostate-specific antigen: a study in a healthy Chinese male population. Urology. 63: 722-6. PMID 15072888 DOI: 10.1016/J.UROLOGY.2003.10.066 |
0.441 |
|
| 2004 |
Hsieh CL, Kubo H, Chung LW. Gene therapy for prostate cancer bone metastasis. Gene therapy targeting bone metastasis. Cancer Treatment and Research. 118: 231-90. PMID 15043196 DOI: 10.1007/978-1-4419-9129-4_11 |
0.382 |
|
| 2004 |
Wang R, Xu J, Saramäki O, Visakorpi T, Sutherland WM, Zhou J, Sen B, Lim SD, Mabjeesh N, Amin M, Dong JT, Petros JA, Nelson PS, Marshall FF, Zhau HE, ... Chung LW, et al. PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer. Cancer Research. 64: 1589-94. PMID 14996714 DOI: 10.1158/0008-5472.CAN-03-3331 |
0.651 |
|
| 2004 |
Edlund M, Sung SY, Chung LW. Modulation of prostate cancer growth in bone microenvironments. Journal of Cellular Biochemistry. 91: 686-705. PMID 14991761 DOI: 10.1002/jcb.10702 |
0.549 |
|
| 2004 |
Cinar B, Yeung F, Konaka H, Mayo MW, Freeman MR, Zhau HE, Chung LW. Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells. The Biochemical Journal. 379: 421-31. PMID 14715080 DOI: 10.1042/Bj20031661 |
0.76 |
|
| 2004 |
Hsieh CL, Gardner TA, Miao L, Balian G, Chung LW. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells. Cancer Gene Therapy. 11: 148-55. PMID 14695756 DOI: 10.1038/sj.cgt.7700665 |
0.629 |
|
| 2004 |
Rubin J, Chung LW, Fan X, Zhu L, Murphy TC, Nanes MS, Rosen CJ. Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis. The Prostate. 58: 41-9. PMID 14673951 DOI: 10.1002/PROS.10299 |
0.537 |
|
| 2004 |
Benjamin MS, Li Y, Otto K, Chen C, Choo C, Waddell D, Chung LWK, Simons J, Dong J. A custom cDNA microarray confirms differential transcription factor regulation between neoplastic and non-neoplastic prostatic epithelial cells Journal of Clinical Oncology. 22: 9656-9656. DOI: 10.1200/jco.2004.22.90140.9656 |
0.569 |
|
| 2003 |
Chung LW, Hsieh CL, Law A, Sung SY, Gardner TA, Egawa M, Matsubara S, Zhau HE. New targets for therapy in prostate cancer: modulation of stromal-epithelial interactions. Urology. 62: 44-54. PMID 14607217 DOI: 10.1016/S0090-4295(03)00796-9 |
0.669 |
|
| 2003 |
Davis R, Jia D, Cinar B, Sikka SC, Moparty K, Zhau HE, Chung LW, Agrawal KC, Abdel-Mageed AB. Functional androgen receptor confers sensitization of androgen-independent prostate cancer cells to anticancer therapy via caspase activation. Biochemical and Biophysical Research Communications. 309: 937-45. PMID 13679064 DOI: 10.1016/J.Bbrc.2003.08.096 |
0.522 |
|
| 2003 |
Wang C, Yeung F, Liu PC, Attar RM, Geng J, Chung LW, Gottardis M, Kao C. Identification of a novel transcription factor, GAGATA-binding protein, involved in androgen-mediated expression of prostate-specific antigen. The Journal of Biological Chemistry. 278: 32423-30. PMID 12782640 DOI: 10.1074/Jbc.M207862200 |
0.801 |
|
| 2003 |
Kubo H, Gardner TA, Wada Y, Koeneman KS, Gotoh A, Yang L, Kao C, Lim SD, Amin MB, Yang H, Black ME, Matsubara S, Nakagawa M, Gillenwater JY, Zhau HE, ... Chung LW, et al. Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer. Human Gene Therapy. 14: 227-41. PMID 12639303 DOI: 10.1089/10430340360535788 |
0.585 |
|
| 2003 |
Zhao YG, Xiao AZ, Newcomer RG, Park HI, Kang T, Chung LW, Swanson MG, Zhau HE, Kurhanewicz J, Sang QX. Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells. The Journal of Biological Chemistry. 278: 15056-64. PMID 12586837 DOI: 10.1074/Jbc.M210975200 |
0.377 |
|
| 2003 |
Chung LW. Prostate carcinoma bone-stroma interaction and its biologic and therapeutic implications. Cancer. 97: 772-8. PMID 12548574 DOI: 10.1002/cncr.11140 |
0.468 |
|
| 2002 |
Sung SY, Chung LW. Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting. Differentiation; Research in Biological Diversity. 70: 506-21. PMID 12492493 DOI: 10.1046/j.1432-0436.2002.700905.x |
0.443 |
|
| 2002 |
Yeung F, Chung LW. Molecular basis of co-targeting prostate tumor and stroma. Journal of Cellular Biochemistry. Supplement. 38: 65-72. PMID 12046851 DOI: 10.1002/Jcb.10044 |
0.794 |
|
| 2002 |
Hsieh CL, Yang L, Miao L, Yeung F, Kao C, Yang H, Zhau HE, Chung LW. A novel targeting modality to enhance adenoviral replication by vitamin D(3) in androgen-independent human prostate cancer cells and tumors. Cancer Research. 62: 3084-92. PMID 12036918 |
0.767 |
|
| 2002 |
Tang S, Bhatia B, Maldonado CJ, Yang P, Newman RA, Liu J, Chandra D, Traag J, Klein RD, Fischer SM, Chopra D, Shen J, Zhau HE, Chung LW, Tang DG. Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. The Journal of Biological Chemistry. 277: 16189-201. PMID 11839751 DOI: 10.1074/Jbc.M111936200 |
0.676 |
|
| 2002 |
Yeung F, Law WK, Yeh CH, Westendorf JJ, Zhang Y, Wang R, Kao C, Chung LW. Regulation of human osteocalcin promoter in hormone-independent human prostate cancer cells. The Journal of Biological Chemistry. 277: 2468-76. PMID 11684680 DOI: 10.1074/Jbc.M105947200 |
0.812 |
|
| 2001 |
Chung LW. CO-TARGETING PROSTATE CANCER AND BONE STROMA THROUGH TUMOR-RESTRICTIVE GENE THERAPY The Japanese Journal of Urology. 92: 53-54. DOI: 10.5980/jpnjurol.92.53 |
0.495 |
|
| 2000 |
Shirakawa T, Gotoh A, Wada Y, Kamidono S, Ko SC, Kao C, Gardner TA, Chung LWK. Tissue-specific promoters in gene therapy for the treatment of prostate cancer Molecular Urology. 4: 73-82. PMID 12006246 DOI: 10.1089/10915360050138620 |
0.623 |
|
| 2000 |
Yeung F, Li X, Ellett J, Trapman J, Kao C, Chung LW. Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells. The Journal of Biological Chemistry. 275: 40846-55. PMID 11006269 DOI: 10.1074/Jbc.M002755200 |
0.827 |
|
| 2000 |
Zhau HE, Li CL, Chung LW. Establishment of human prostate carcinoma skeletal metastasis models. Cancer. 88: 2995-3001. PMID 10898343 DOI: 10.1002/1097-0142(20000615)88:12+<2995::AID-CNCR15>3.0.CO;2-Y |
0.516 |
|
| 2000 |
Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, Ozen M, Pathak S, Chung LW. LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. The Prostate. 44: 91-103 Jul 1;44(2). PMID 10881018 DOI: 10.1002/1097-0045(20000701)44:2<91::Aid-Pros1>3.0.Co;2-L |
0.671 |
|
| 1999 |
Koeneman KS, Yeung F, Chung LW. Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. The Prostate. 39: 246-61. PMID 10344214 DOI: 10.1002/(SICI)1097-0045(19990601)39:4<246::AID-PROS5>3.0.CO;2-U |
0.81 |
|
| 1998 |
Wu TT, Sikes RA, Cui Q, Thalmann GN, Kao C, Murphy CF, Yang H, Zhau HE, Balian G, Chung LW. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. International Journal of Cancer. Journal International Du Cancer. 77: 887-94. PMID 9714059 DOI: 10.1002/(Sici)1097-0215(19980911)77:6<887::Aid-Ijc15>3.0.Co;2-Z |
0.537 |
|
| 1998 |
Chen ME, Lin SH, Chung LW, Sikes RA. Isolation and characterization of PAGE-1 and GAGE-7. New genes expressed in the LNCaP prostate cancer progression model that share homology with melanoma-associated antigens. The Journal of Biological Chemistry. 273: 17618-25. PMID 9651357 DOI: 10.1074/Jbc.273.28.17618 |
0.597 |
|
| 1998 |
Gotoh A, Ko SC, Shirakawa T, Cheon J, Kao C, Miyamoto T, Gardner TA, Ho LJ, Cleutjens CB, Trapman J, Graham FL, Chung LW. Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer. The Journal of Urology. 160: 220-9. PMID 9628654 DOI: 10.1016/S0022-5347(01)63094-5 |
0.633 |
|
| 1997 |
Pathak S, Nemeth MA, Multani AS, Thalmann GN, von Eschenbach AC, Chung LW. Can cancer cells transform normal host cells into malignant cells? British Journal of Cancer. 76: 1134-8. PMID 9365160 DOI: 10.1038/bjc.1997.524 |
0.36 |
|
| 1997 |
Cleutjens KBJM, Van Der Korput HAGM, Ehren-van Eekelen CC, Sikes RA, Fasciana C, Chung LW, Trapman J. A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans Molecular Endocrinology. 11: 1256-1265. PMID 9259317 DOI: 10.1210/Mend.11.9.9974 |
0.593 |
|
| 1997 |
Zhau HE, Goodwin TJ, Chang SM, Baker TL, Chung LW. Establishment of a three-dimensional human prostate organoid coculture under microgravity-simulated conditions: evaluation of androgen-induced growth and PSA expression. In Vitro Cellular & Developmental Biology. Animal. 33: 375-80. PMID 9196896 DOI: 10.1007/s11626-997-0008-3 |
0.629 |
|
| 1997 |
Hyytinen ER, Thalmann GN, Zhau HE, Karhu R, Kallioniemi OP, Chung LW, Visakorpi T. Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model. British Journal of Cancer. 75: 190-5. PMID 9010025 DOI: 10.1038/bjc.1997.32 |
0.536 |
|
| 1997 |
Ko SC, Gotoh A, Thalmann GN, Zhau HE, Johnston DA, Zhang WW, Kao C, Chung LW. Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model. Human Gene Therapy. 7: 1683-91. PMID 8886839 DOI: 10.1089/Hum.1996.7.14-1683 |
0.566 |
|
| 1997 |
Chung LW, Zhau HE, Wu TT. Development of human prostate cancer models for chemoprevention and experimental therapeutics studies Journal of Cellular Biochemistry. 67: 174-181. DOI: 10.1002/(SICI)1097-4644(1997)28/29+<174::AID-JCB21>3.0.CO;2-G |
0.568 |
|
| 1996 |
Thalmann GN, Sikes RA, Chang SM, Johnston DA, von Eschenbach AC, Chung LW. Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer. Journal of the National Cancer Institute. 88: 794-801. PMID 8637045 DOI: 10.1093/Jnci/88.12.794 |
0.638 |
|
| 1996 |
Zhau HY, Zhou J, Symmans WF, Chen BQ, Chang SM, Sikes RA, Chung LW. Transfected neu oncogene induces human prostate cancer metastasis. The Prostate. 28: 73-83. PMID 8604395 DOI: 10.1002/(Sici)1097-0045(199602)28:2<73::Aid-Pros1>3.0.Co;2-O |
0.493 |
|
| 1996 |
Bosland MC, Chung LWK, Greenberg NM, Ho SM, Isaacs JT, Lane K, Peehl DM, Thompson TC, Van Steenbrugge GJ, Van Weerden WM. Recent advances in the development of animal and cell culture models for prostate cancer research: A minireview Urologic Oncology. 2: 99-128. DOI: 10.1016/S1078-1439(96)00077-4 |
0.536 |
|
| 1996 |
Chung LW. Commentary on Tumor Suppressor Gene, Distal to BRCA-1, in Prostate Cancer Journal of Urology. 155: 430-431. DOI: 10.1016/S0022-5347(01)66410-3 |
0.541 |
|
| 1995 |
Gleave ME, Chung LWK. Stromal-epithelial interaction affecting prostate tumour growth and hormonal responsiveness Endocrine Related Cancer. 2: 243-265. DOI: 10.1677/erc.0.0020243 |
0.492 |
|
| 1994 |
Wu HC, Hsieh JT, Gleave ME, Brown NM, Pathak S, Chung LW. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. International Journal of Cancer. 57: 406-12. PMID 8169003 DOI: 10.1002/ijc.2910570319 |
0.541 |
|
| 1994 |
Freeman MR, Bagli DJ, Lamb CC, Guthrie PD, Uchida T, Slavin RE, Chung LW. Culture of a prostatic cell line in basement membrane gels results in an enhancement of malignant properties and constitutive alterations in gene expression. Journal of Cellular Physiology. 158: 325-36. PMID 8106569 DOI: 10.1002/jcp.1041580215 |
0.312 |
|
| 1994 |
Zhau HE, Hong SJ, Chung LW. A fetal rat urogenital sinus mesenchymal cell line (rUGM): accelerated growth and conferral of androgen-induced growth responsiveness upon a human bladder cancer epithelial cell line in vivo. International Journal of Cancer. 56: 706-14. PMID 7508897 DOI: 10.1002/ijc.2910560516 |
0.426 |
|
| 1993 |
Hoosein NM, Logothetis CJ, Chung LW. Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. The Journal of Urology. 149: 1209-13. PMID 8097794 DOI: 10.1016/S0022-5347(17)36349-8 |
0.467 |
|
| 1992 |
Gleave ME, Hsieh JT, von Eschenbach AC, Chung LW. Prostate and bone fibroblasts induce human prostate cancer growth in vivo: implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis Journal of Urology. 147: 1151-1159. PMID 1372662 DOI: 10.1016/S0022-5347(17)37506-7 |
0.623 |
|
| 1990 |
Guthrie PD, Freeman MR, Liao ST, Chung LW. Regulation of gene expression in rat prostate by androgen and beta-adrenergic receptor pathways. Molecular Endocrinology (Baltimore, Md.). 4: 1343-53. PMID 2172800 DOI: 10.1210/mend-4-9-1343 |
0.527 |
|
| 1978 |
Chung LW, Coffey DS. Androgen glucuronides. I. Direct formation in rat accessory sex organs. Steroids. 30: 223-43. PMID 929647 DOI: 10.1016/0039-128X(77)90084-8 |
0.345 |
|
| Show low-probability matches. |